Researchers identify drug candidate for treating spinal muscular atrophy
Wednesday, November 4, 2009 - 15:42
in Health & Medicine
A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants. This is the finding of a research collaboration involving Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory (CSHL) and scientists from Paratek Pharmaceuticals and Rosalind Franklin University of Medicine and Science.
Read the whole article on Physorg
More from Physorg
Related
- Researchers identify drug candidate for treating spinal muscular atrophyWed, 4 Nov 2009, 15:44:09 EST
- Rare window on spinal muscular atrophy geneticsTue, 7 Apr 2009, 6:14:56 EDT
- Researchers discover target that could ease spinal muscular atrophy symptomsWed, 7 Jan 2009, 13:17:33 EST
- ISU researchers find possible treatment for spinal muscular atrophyMon, 27 Jul 2009, 14:37:03 EDT
- Penn researchers gain new insights on spinal muscular atrophyThu, 29 May 2008, 15:14:52 EDT